HEPION PHARMACEUTICALS
Hepion Pharmaceuticals provides development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV).
HEPION PHARMACEUTICALS
Industry:
Biotechnology Life Science Medical Pharmaceutical Service Industry
Founded:
2013-01-01
Address:
Edison, New Jersey, United States
Country:
United States
Website Url:
http://www.hepionpharma.com
Total Employee:
11+
Status:
Active
Contact:
+1 732 902-4000
Email Addresses:
[email protected]
Total Funding:
105.37 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 GoDaddy DNS Google Google Cloud COVID-19 Akamai Hosted Wistia
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-05-31 | Ciclofilin Pharmaceuticals | Ciclofilin Pharmaceuticals acquired by Hepion Pharmaceuticals | 17 M USD |
Official Site Inspections
http://www.hepionpharma.com Semrush global rank: 2.7 M Semrush visits lastest month: 6.12 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Hepion Pharmaceuticals"
Company Information – Hepion Pharmaceuticals
Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), …See details»
Hepion Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 732 902-4000 Hepion Pharmaceuticals provides the development of targeted therapies for liver disease arising from …See details»
Hepion Pharmaceuticals Inc Company Profile - Overview
Website hepionpharma.com Telephone 1 732 9024000. No of Employees 22. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange HEPA (NASD) EPS XYZ. Net …See details»
Hepion Pharmaceuticals (HEPA) Company Profile & Description
6 days ago Ticker Symbol: HEPA: Exchange: NASDAQ: Stock Type: Common Stock: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001583771: CUSIP …See details»
Hepion Pharmaceuticals Overview | SignalHire Company Profile
Organization Website: hepionpharma.com : Hepion Pharmaceuticals industries Biotech: Headquarters Location: Edison, New Jersey, 08837 US Edison, New Jersey, 08837 U...See details»
Hepion Pharmaceuticals Company Overview, Contact Details
[email protected]: 1%. [email protected]: [email protected]: 1%. [email protected]: …See details»
Hepion Pharmaceuticals Company Profile -Sales, Contacts, …
Hepion Pharmaceuticals is located in Edison, New Jersey. This organization primarily operates in the Pharmaceutical Preparations business / industry within the Chemicals and Allied Products …See details»
Corporate Governance – Hepion Pharmaceuticals
Hepion Pharmaceuticals, Inc. promotes a trustworthy and honest work environment and reinforces the vision of these ethics within the organization. Hepion Pharmaceuticals, Inc. will not tolerate any wrongdoing or impropriety …See details»
Hepion Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The …
View Hepion Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Overview, News & Similar companies - ZoomInfo.com
Mar 5, 2024 Who is Hepion Pharmaceuticals. ContraVir is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non …See details»
Hepion Pharmaceuticals - Company Profile & Staff Directory
Hepion Pharmaceuticals (Nasdaq: HEPA) is a biopharmaceutical company focused on the development of pleiotropic drug therapy for treatment of chronic liver disease. This therapeutic …See details»
Hepion Pharmaceuticals
Feb 18, 2025 Hepion Pharmaceuticals was founded in 2017 with a mission to develop treatments for liver diseases. The company's founders have extensive experience in …See details»
Hepion Pharmaceuticals - Craft
Oct 29, 2024 Hepion Pharmaceuticals (formerly known as ContraVir Pharmaceuticals) is a clinical-stage biopharmaceutical company focused on the development of targeted therapies …See details»
About Hepion – Hepion Pharmaceuticals
Dec 11, 2024 Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the …See details»
Investors – Hepion Pharmaceuticals
Dec 11, 2024 Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the …See details»
Hepion Pharmaceuticals, Inc. - Cruelty Free Investing
Company Website: https://hepionpharma.com Contact: [email protected] ©2025 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization …See details»
Hepion Pharmaceuticals, Inc. Announces Termination of
EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had …See details»
Hepion Pharmaceuticals Announces Management Changes
Sep 6, 2023 Dr. Harrison currently serves as the founder and chairman for both Pinnacle Clinical Research and Summit Clinical Research (an internationally recognized integrated research …See details»
Hepion Pharmaceuticals Announces Reverse Stock Split
Mar 14, 2025 --Hepion Pharmaceuticals, Inc., a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis, hepatocellular carcinoma, …See details»
Hepion Pharmaceuticals Announces $9.0 Million Public Offering
EDISON, N.J., Jan. 22, 2025 — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic …See details»